India, April 6 -- A major Indian pharma giant board approved a Rs800 crore share buyback on April 6, offering shareholders Rs1,475 per share, about 10.9% above the market price. The tender offer covers up to 54 lakh shares, with April 17 set as the record date. It is a clear signal that the company is in good financial health and wants to reward its investors.

With a market cap of Rs. 77,836 Crore, the shares of Aurobindo Pharma Ltd. is currently trading at Rs1,340.00, up 0.47%. Following an Rs800 crore buyback announcement at Rs1,475, the stock reached an intraday high of Rs1,357.90 before settling. It touched an intraday low of Rs1,318.50 earlier in the session.

What just happened? On the morning of April 6, 2026, Aurobindo Pharma's ...